Enzolytics Inc (ENZC)

[Mutat]

In this agreement it states the shareholders will get dividend stocks but the yearly report states on page four that common shares will not get the divi shares.

Sagaliam Acquisition Corp. Announces Novation Agreement with Enzolytics, Inc.
This agreement transferred ownership of Biogenysis, Inc. ("BGEN") and it's IP, patents and associated asset being developed back to ENZC in exchange for a reduction of the price from $450,000,000 to $290,000,000 with the dividend of the purchase shares to come directly to the ENZC shareholders from SAGA.